Polymorphism and pseudopolymorphism of the antibacterial nitrofurantoin

Molecular Crystals and Liquid Crystals Science and Technology Section A: Molecular Crystals and Liquid Crystals

Volumn 278-279, Issue , 1996, Pages 241-264

  Caira, Mino R ^a   Pienaar, Eduard W ^b   Lötter, Antonie P ^b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b NORTH WEST UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA; CHEMICAL MODIFICATION; CRYSTAL STRUCTURE; CRYSTALLIZATION; DECOMPOSITION; DISSOLUTION; HYDRATES; THERMAL EFFECTS;

MONOHYDRATES; NITROFURANTOIN; NITROFURFURYLIDENE AMINOHYDANTOIN; POLYMORPHISM; PSEUDOPOLYMORPHISM; SOLVATES;

ANTIBIOTICS;

EID: 0008209306     PISSN: 1058725X     EISSN: None     Source Type: Journal    
DOI: 10.1080/10587259608042194     Document Type: Article

References (31)

1. A. Martin, Physical Pharmacy, (Lea & Febiger, Philadelphia, 4th Ed. 1993), p.331.
2. J.K. Haleblian, J. Pharm. Sci., 64, 1269(1975).
3. S.R. Byrn. Solid-state chemistry of drugs. (Academic Press, New York, 1982), p. 143.
4. L. Borka and J.K. Haleblian, Acta Pharm. Jugoslav., 40, 71(1990).
5. W.I. Higuchi, P.D. Bernardo and S.C. Mehta, J. Pharm. Sci., 56, 200(1967).
6. P.M. Dean, in Molecular Foundations of Drug-Receptor Interaction, (Cambridge University Press, England, 1987), pp188-235.
7. MARTINDALE: The Extra Pharmacopoeia, (The Pharmaceutical Press, London, 28th Ed. 1982), p. 1048.
8. M. Otsuka, R. Teraoka and Y. Matsuda, Chem. Pharm. Bull., 38, 833(1990).
9. M. Otsuka, R. Teraoka and Y. Matsuda, Pharm. Res. 8, 1066(1991).
10. M. Otsuka, R. Teraoka and Y. Matsuda, Chem. Pharm. Bull., 39, 2667(1991).
11. M. Otsuka and Y. Matsuda, J. Pharm. Pharmacol, 45, 406(1993).
12. P.V. Marshall and P. York. Int. J. Pharm., 55, 257(1989).
13. N. Garti and F. Tibika, Drug Dev. Indust. Pharm., 6, 379(1980).
14. E.W. Pienaar, M.R. Caira and A.P. Lötter, J. Crystallogr. Spectr. Res., 23, 739(1993).
15. E.W. Pienaar, M.R. Caira and A.P. Lötter, J. Crystallogr. Spectr. Res., 23, 785(1993).
16. K. Yvon, W. Jeitschko and E.J. Parthè, J. Appl. Cryst., 10, 73(1977).
17. A.P. Simonelli, S.C. Mehta and W.I. Higuchi, J. Pharm. Sci., 58, 538(1969).
18. P. Singh, S.J. Desai, D.R. Flanagan, A.P. Simonelli and W.I. Higuchi, J. Pharm. Sci., 57, 959(1968).
19. A.P Lötter, D.R. Flanagan, N.R. Palepu and J.K. Guillory, Pharm. Technol., 7, 56(1983).
20. United States Pharmacopoeia XXII, (Mack Publishing company, Easton, 1990), p. 1578.
21. G.M. Sheldrick, SHELX86, (G.M. Sheldrick, C. Kruger and R. Goddard, Eds.) Crystallographic computing 3, (Oxford University Press, 1986), p. 175.
22. G.M. Sheldrick, SHELX76, A system of computer programs for X-ray structure determination. (University of Cambridge, England, 1976).
23. J.J. Gerber, M.R. Caira and A.P. Lötter, J. Crystallogr. Spectr. Res., 23, 863(1993).
24. A. Miyamae, S. Kitamura, T. Tada, S. Koda and T. Yasuda, J. Pharm. Sci., 80, 995(1991).
25. V. Bertolasi, P. Gilli, V. Ferretti and G. Gilli, Acta Crystallogr., 49, 741(1993).
26. P.R. Perrier and S.R. Byrn, J. Org. Chem., 47, 4671(1982).
27. Program MOLMAP: L.J. Barbour, (Ph.D Thesis, University of Cape Town, 1994).
28. I. Bar and J. Bernstein, J. Pharm. Sci., 74, 255(1985).
29. M.R. Caira, L.R. Nassimbeni, M.L. Niven, W.-D. Schubert, E. Weber and N. Dörpinghaus, J. Chem. Soc.,Perkin Trans.2, 2129(1990).
30. E. Weber and H.P. Josel, J. Incl. Phenom., 1, 79(1983).
31. M. Otsuka, R. Teraoka and Y. Matsuda, Pharm. Res. 9, 307(1992).